Dermatology · Barboursville, WV
NPI
1073503223
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6007 US Route 60 E, Suite 130
Barboursville, WV, 25504
Phone (304) 733-3333
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
2,033 services
Medicare patients, 2024
570
Average age 75
Drug cost, 2024
$993K
862 prescriptions
Company payments, 2025
$4,148
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy A Vaughan II was code 17003 (destruction skin lesion), 430 times for 110 patients. In total Amy A Vaughan II billed 2,033 services in 79 codes, and Medicare paid $174K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 430 | 110 | $4.16 | $1,790 |
| 99213 Office E&M - Established | Office | 206 | 169 | $60.39 | $12K |
| 17000 Destruction Skin Lesion | Office | 195 | 165 | $35.60 | $6,942 |
| 99214 Office E&M - Established | Office | 154 | 140 | $78.61 | $12K |
| 12032 Wound Repair - All Levels | Office | 80 | 78 | $158.81 | $13K |
| 17110 Destruction Skin Lesion | Office | 61 | 58 | $73.56 | $4,487 |
| 99212 Office E&M - Established | Office | 60 | 55 | $38.24 | $2,295 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 58 | 30 | $295.26 | $17K |
| 96567 Skin | Office | 50 | 30 | $77.67 | $3,883 |
| 11643 Skin Lesion Excision | Office | 43 | 41 | $225.04 | $9,677 |
| 11603 Skin Lesion Excision | Office | 41 | 36 | $121.73 | $4,991 |
| 11606 Skin Lesion Excision | Office | 33 | 32 | $331.26 | $11K |
| 11604 Skin Lesion Excision | Office | 33 | 31 | $212.79 | $7,022 |
| 96372 Injection Administration | Office | 30 | 18 | $9.46 | $284 |
| 12052 Wound Repair - All Levels | Office | 30 | 30 | $124.97 | $3,749 |
By year: 2022 $357K for 6,613 services; 2023 $331K for 5,976 services; 2024 $174K for 2,033 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy A Vaughan II prescribed most often to Medicare patients was Doxycycline Hyclate, with 93 prescriptions and refills. In total Amy A Vaughan II wrote 862 Medicare prescriptions that cost $993K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 93 | 125 | 42 | $1,464 |
| Fluorouracil Generic | 74 | 75 | 70 | $4,950 |
| Clobetasol Propionate Generic | 70 | 88 | 41 | $4,895 |
| Metronidazole Generic | 47 | 48 | 23 | $3,981 |
| Dupixent Syringe Dupilumab | 44 | 44 | Under 11 | $172K |
| Triamcinolone Acetonide Generic | 41 | 63 | 32 | $676 |
| Ketoconazole Generic | 36 | 36 | 14 | $670 |
| Spironolactone Generic | 31 | 52 | Under 11 | $548 |
| Skyrizi Risankizumab-Rzaa | 29 | 81 | Under 11 | $597K |
| Hydrocortisone Generic | 29 | 29 | 15 | $185 |
| Hydroxychloroquine Sulfate Generic | 26 | 52 | Under 11 | $485 |
| Clindamycin Phosphate Generic | 21 | 24 | 11 | $1,005 |
| Cephalexin Generic | 19 | 23 | 14 | $89.69 |
| Nystatin Generic | 18 | 20 | Under 11 | $312 |
| Minocycline Hcl Generic | 17 | 21 | Under 11 | $301 |
Brand drugs: 166 claims; generic drugs: 696 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy A Vaughan II $4,148 ($4,148 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $3,614.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 64 | $3,614 |
| Galderma Laboratories, L.P. GALD.SW | 16 | $229 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $80.92 |
| Arcutis Biotherapeutics, Inc. ARQT | 3 | $53.15 |
| Hill Dermaceuticals, Inc. | 2 | $45.53 |
| Organon LLC OGN | 2 | $32.63 |
| Janssen Biotech, Inc. JNJ | 2 | $29.63 |
| LEO Pharma Inc. | 1 | $28.83 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $19.39 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $15.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.